Upasana Ganguly

244 Acharya Jagadish Chandra Bose Road
Kolkata, WB 700020, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Alpha-synuclein interaction with mitochondria is the final mechanism of ferroptotic death induced by erastin in SH-SY5Y cells.

Alpha-synuclein interaction with mitochondria is the final mechanism of ferroptotic death induced by erastin in SH-SY5Y cells.

Journal: Free radical research

Published: April 04, 2024

GLUT inhibitor WZB117 induces cytotoxicity with increased production of amyloid-beta peptide in SH-SY5Y cells preventable by beta-hydroxybutyrate: implications in Alzheimer's disease.

GLUT inhibitor WZB117 induces cytotoxicity with increased production of amyloid-beta peptide in SH-SY5Y cells preventable by beta-hydroxybutyrate: implications in Alzheimer's disease.

Journal: Pharmacological reports : PR

Published: October 28, 2022

Protective effects of cyclosporine A on neurodegeneration and motor impairment in rotenone-induced experimental models of Parkinson's disease.

Protective effects of cyclosporine A on neurodegeneration and motor impairment in rotenone-induced experimental models of Parkinson's disease.

Journal: European journal of pharmacology

Published: May 08, 2022

Immunotherapeutic interventions in Parkinson's disease: Focus on α-Synuclein.

Immunotherapeutic interventions in Parkinson's disease: Focus on α-Synuclein.

Journal: Advances in protein chemistry and structural biology

Published: March 20, 2022

Efficacy and Cost-Effectiveness of Anti-VEGF for Treating Diabetic Retinopathy in the Indian Population.

Efficacy and Cost-Effectiveness of Anti-VEGF for Treating Diabetic Retinopathy in the Indian Population.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: May 03, 2021

Alpha-Synuclein as a Biomarker of Parkinson's Disease: Good, but Not Good Enough.

Alpha-Synuclein as a Biomarker of Parkinson's Disease: Good, but Not Good Enough.

Journal: Frontiers in aging neuroscience

Published: April 29, 2021

Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits.

Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits.

Journal: Expert review of anti-infective therapy

Published: March 19, 2021

Cross-immunity and trained immunity in explaining variable COVID-19 mortality-Guidance for future pandemics.

Cross-immunity and trained immunity in explaining variable COVID-19 mortality-Guidance for future pandemics.

Journal: Journal of medical virology

Published: March 02, 2021

COVID-19 and emerging spinal cord complications: A systematic review.

COVID-19 and emerging spinal cord complications: A systematic review.

Journal: Multiple sclerosis and related disorders

Published: October 07, 2020

Meningoencephalitis associated with COVID-19: a systematic review.

Meningoencephalitis associated with COVID-19: a systematic review.

Journal: Journal of neurovirology

Published: August 14, 2020

Oxidative Stress, Neuroinflammation, and NADPH Oxidase: Implications in the Pathogenesis and Treatment of Alzheimer's Disease.

Oxidative Stress, Neuroinflammation, and NADPH Oxidase: Implications in the Pathogenesis and Treatment of Alzheimer's Disease.

Journal: Oxidative medicine and cellular longevity

Published: July 23, 2020

COVID-19 in India: Are Biological and Environmental Factors Helping to Stem the Incidence and Severity?

COVID-19 in India: Are Biological and Environmental Factors Helping to Stem the Incidence and Severity?

Journal: Aging and disease

Published: March 26, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026